scPharmaceuticals Inc. (SCPH) Tops Q1 EPS by 9c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.28), $0.09 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $1.68 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Deutsche Bank Starts DexCom (DXCM) at Buy